If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
26.50    0.00 (0.00%)
Bid:
26.00
Ask:
27.00
Spread: 1.00 (3.846%)
Market Cap: £111.90m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Three additional university partnerships

15 Dec 2015 07:00

RNS Number : 0360J
Mercia Technologies PLC
15 December 2015
 



RNS Reach

15 December 2015

 

Mercia Technologies PLC

Further expansion into the North of England with three additional university partnerships

Mercia Technologies PLC (AIM: MERC, "Mercia"), a Midlands-based investment group building, funding and commercialising technology businesses in the UK, has further expanded its operations into the North of England, through university partnerships with the University of York, the University of Liverpool and Liverpool John Moores University. This takes the total of Mercia's university partnerships to 14, across the Midlands, the North of England and Scotland.

The three new university partnerships will provide further opportunities for Mercia to tap into the wealth of early stage technology businesses available in the North of England.

Mercia has already expanded its operations to Scotland, with the opening of an Edinburgh office, alongside two partnerships with the University of Strathclyde and Abertay University, announced on 27 October 2015. Mercia plans to open an office in the North of England in order to work more closely with its partner universities within the region in 2016.

Commenting on the partnerships, Mark Payton, CEO of Mercia Technologies PLC, said:

"Since Mercia Technologies listed on AIM last year, we have seen the number of our university partnerships increase from 9 to 14. At the same time, our third-party funds under management through Mercia Fund Management ("MFM") have grown markedly, enabling us to provide seed and early stage investment capital for a growing portfolio of exciting technology-backed businesses with high growth potential.

"Through our Complete Capital Solution we are able to support young and growing businesses via MFM with the potential over the medium to long term to provide material direct investment from Mercia Technologies PLC.

"The North of England has a wealth of untapped potential in terms of scalable technology businesses, and we look forward to working closely with the technology transfer teams at each of our new university partners to build, fund, and support the accelerated growth of their promising spinout companies."

For further information contact:

 

Mercia Technologies PLC (www.merciatechnologies.com)

+44 (0) 330 223 1430

Mark Payton, Chief Executive

Martin Glanfield, Chief Financial Officer

Cenkos Securities

+44 (0) 20 7397 8900

Ivonne Cantu / Mark Connelly (NOMAD)

Instinctif Partners

+44 (0) 20 7457 2020

Kay Larsen / Lauren Foster

 

 

 

Note to editors

Mercia creates, funds and develops technology businesses nationally with an emphasis on the Midlands, the North of England and Scotland. The Group facilitates technology transfer, company formation, incubation, commercialisation and investment, with approximately 50% of its investments being university spinouts. Mercia invests across technology sectors in which it has deep sector expertise.

 

The Mercia model is one of patiently nurturing businesses via its third party funds under management and then scaling them with direct investment at the point of commercial traction. Through this, Mercia has a well seeded portfolio and pipeline of investments - its 'emerging stars'.

 

Mercia's shares started trading on AIM on 18 December 2014 and since then up until 3 December 2015, Mercia has invested over £20.0million directly across its portfolio of emerging stars, which in themselves have attracted total investment of approximately £70.0million alongside Mercia and its third party funds. In addition to its direct investments, Mercia (via MFM's funds under management) has invested over £20.0million to build its portfolio of potential future emerging stars.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAAALFENSFAF
Date   Source Headline
25th Nov 20217:00 amRNSNVT performance fee entitlement and trading update
22nd Nov 20217:00 amRNSInvestor Presentation
2nd Nov 20217:00 amRNSMercia announces a new direct investment
27th Oct 20217:00 amRNSNotice of Interim Results
26th Oct 20217:00 amRNSMercia announces new direct investment
21st Oct 20217:00 amRNSPublication of newsletter
14th Sep 202110:21 amRNSResult of AGM
14th Sep 20217:00 amRNSAGM Statement
3rd Sep 20217:00 amRNSInvestment into Locate Bio
10th Aug 20217:00 amRNSMercia accredited to deliver Recovery Loan Scheme
4th Aug 20217:00 amRNSnDreams appoints new Non-executive Chair
30th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
15th Jul 20217:00 amRNSNotification of Major Holdings
12th Jul 20217:00 amRNSGrant of Options
8th Jul 20212:56 pmRNSDirector/PDMR Dealings
6th Jul 20217:00 amRNSPreliminary results
24th Jun 20217:00 amRNSInvestor Presentation
23rd Jun 20213:16 pmRNSPerformance fee entitlement and trading update
10th May 20217:00 amRNSPublication of "The Insight" Newsletter
15th Apr 20217:00 amRNSNotice of Results
12th Apr 20217:00 amRNSVirtual shareholder event
6th Apr 20212:37 pmRNSMyHealthChecked plc signs major contract
5th Mar 202112:46 pmRNSNotification of Major Holdings
4th Mar 20214:09 pmRNSDirector/PDMR Dealings
3rd Mar 20217:00 amEQSEdison Investment Research Limited: Mercia Asset Management (MERC): The UK's top regional investor
1st Mar 20213:31 pmRNSTrading Update
1st Mar 20213:27 pmRNSSale of Oxford Genetics Limited
23rd Feb 20217:00 amRNSSoccer Manager receives £3.0million investment
2nd Feb 20217:00 amRNSSoftware and eCommerce portfolio update
29th Jan 20217:00 amRNSChange of Auditor
8th Dec 20207:00 amRNSQuarterly newsletter
2nd Dec 20207:00 amRNSPerformance fee entitlement
1st Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSInvestor Presentation
6th Nov 20207:00 amRNSNotice of Results and Investor Presentations
3rd Nov 20207:00 amRNSBoard Appointment
30th Oct 20207:30 amRNSNew direct investment into Sense Biodetection
19th Oct 20207:00 amRNSSuccessful exit of Clear Review
7th Oct 20207:00 amRNSWarwick Acoustics Update
25th Sep 20207:00 amRNSDirector/PDMR Dealings
24th Sep 202010:29 amRNSResult of AGM
24th Sep 20207:00 amRNSAGM Statement
18th Sep 20207:00 amRNSLife Sciences’ Portfolio Update
24th Aug 20207:00 amRNSGrant of Options
31st Jul 20207:03 amRNSPublication of Annual Report
29th Jul 20202:31 pmRNSDirector/PDMR Dealings
14th Jul 20207:00 amRNSPreliminary results
9th Jul 20207:00 amRNSSale of The Native Antigen Company
1st Jul 20207:00 amRNSPortfolio company MIP Diagnostics raises £5.1m
11th Jun 20207:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.